| Pharmaceutical active ingredients: |
| Hydroxyapatite |
| Available forms, composition and doses of Alveograf: |
| N / A |
| Alveograf medical category: |
| Human:Agents affecting bone metabolism |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M05BX - Other drugs affecting bone structure and mineralization |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Aluphos | Aluminum Phosphate | Unidentified Pharmaceutical Company |
| Alural | Bromisoval | Unidentified Pharmaceutical Company |
| Alurene | Chlorothiazide | Unidentified Pharmaceutical Company |
| Alutyl | Cinchophen | Unidentified Pharmaceutical Company |
| Aluviran | Lopinavir | Unidentified Pharmaceutical Company |
| Alvinine | Xenysalate | Unidentified Pharmaceutical Company |
| Alvinol | Ethchlorvynol | Unidentified Pharmaceutical Company |
| Alvyl | Polyvinyl Alcohol | Unidentified Pharmaceutical Company |
| Alzapam | Lorazepam | Unidentified Pharmaceutical Company |
| Alzodef | Calcium Carbimide | Unidentified Pharmaceutical Company |